Fast Personalized Therapeutic Choices Thanks to the Light-Based Sorting of Biomolecules and Cells

Press Release / 6.11.2017

Biomolecules and cells circulating in the blood carry diagnostic information, the analysis of which makes highly effective, individualized therapies possible. In order to tap this information, scientists from the Fraunhofer Institute for Laser Technology ILT have developed a microchip-based diagnostic device: The “AnaLighter” analyzes and sorts clinically relevant biomolecules and cells in a blood test with light. As a result, physicians can make early diagnoses, for example, of tumor and cardiovascular diseases and initiate patient-specific therapies with great efficacy. Experts from Fraunhofer ILT will be presenting this technology at the COMPAMED 2017 in Düsseldorf from November 13 to 16.